Davis's Drug Guide
- abrocitinib
- adapalene
- aducanumab
- anacaulase
- andexanet alfa
- ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITORS
- angiotensin II
- ANGIOTENSIN II RECEPTOR ANTAGONISTS
- anifrolumab
- aprepitant
- atogepant
- bempedoic acid/ezetimibe
- brentuximab vedotin
- budesonide (inhalation)
- budesonide (systemic)
- cabotegravir
- cabotegravir/rilpivirine
- clascoterone
- danaparoid sodium
- daridorexant
- decitabine/cedazuridine
- defibrotide
- deucravacitinib
- doxepin (systemic)
- emapalumab
- faricimab
- FENTANYL (transmucosal)
- fezolinetant
- finerenone
- fostamatinib
- fostemsavir
- halobetasol/tazarotene
- inclisiran
- infigratinib
- lanthanum
- lecanemab
- levodopa
- mobocertinib
- molnupiravir
- monomethyl fumarate
- naxitamab
- nirmatrelvir/ritonavir
- olanzapine/samidorphan
- opicapone
- ozenoxacin
- patisiran
- potassium chloride
- prabotulinumtoxina
- protamine
- prucalopride succinate
- relugolix/estradiol/norethindrone
- rifamycin
- ritlecitinib
- ruxolitinib (topical)
- selinexor
- senna
- short ragweed pollen allergen extract
- sirolimus (systemic)
- sodium phenylbutyrate/taurursodiol
- sulbactam/durlobactam
- teclistamab
- teprotumumab
- tirzepatide
- tisotumab vedotin
- tivozanib
- trifarotene
- turmeric
- varenicline (systemic)
- vestronidase alfa-vjbk
- voclosporin
- zavegepant
- zuranolone